1351 results for leukemia
Refine Your Search
Advances in Treatment for Chronic Lymphocytic Leukemia (CLL)
Topics Covered We invite you to learn more about: Current and emerging therapies for CLL Managing side effects to promote a better quality of lif…
Chronic Myelomonocytic Leukemia (CMML) Clinical Trial Travel Fund
Assists eligible patients diagnosed with Chronic Myelomonocytic Leukemia, being evaluated for or participating in a clinical trial, who are United Sta…
Exploiting Novel Therapeutic Vulnerabilities in Chronic Myelomonocytic Leukemia
The overall objective of this project is to identify novel pathways that may be targeted for therapeutic benefit in CMML. We have identified abnormal …
Key Insights: Treating Adult Acute Lymphoblastic Leukemia (ALL)
Education Resources
Chronic Myeloid Leukemia: Patient Experience Not Well Understood
Chronic Myeloid Leukemia: Patient Experience Not Well Understood FOR IMMEDIATE RELEASE Linda House -- [email protected] Andrea Greif --…
What’s on the Horizon for Chronic Lymphocytic Leukemia?
Topics Covered We invite you to learn more about: Diagnosing chronic lymphocytic leukemia (CLL) New and emerging therapies Supportive care and …
The Leukemia & Lymphoma Society Honors Dr. Sherie Morrison
On Wednesday, November , The Leukemia & Lymphoma Society California Southland Chapter held a dinner to honor Dr. Sherie Morrison, a preeminent researc…
What's on the Horizon for Chronic Myeloid Leukemia?
[Click here to enlarge.] Topics Covered We invite you to learn more about: Audio Replay …
LLS PedAL: Precision Medicine for Children with Leukemia
As part of The LLS Children’s Initiative, LLS is working with a team of renowned pediatric oncologists to lay the groundwork for a global precision me…
Leukemia, Lymphoma, Hodgkin’s Disease & Myeloma Support Group - Middletown
The group will address specific issues related to a blood cancer diagnosis and will provide an opportunity for attendees to discuss concerns, anxietie…
Kura Oncology’s Menin Inhibitor Ziftomenib Selected for The Leukemia & Lymphoma Society’s Pediatric Acute Leukemia (PedAL) Master Clinical Trial
SAN DIEGO, December , – Kura Oncology, Inc. (NASDAQ: KURA), a biopharmaceutical company committed to realizing the promise of precision medicines fo…
News Release
Mechanisms of oncogenic transcription in NPM1-mutant myeloid leukemia
NPM1-mutated leukemia is the most common AML in adult and characterized by upregulations of HOXA/B genes and MEIS1. Given the importance of oncogenic …
Functionalizing novel PHIP variants in ancestry-specific acute myeloid leukemia
AML risk stratification established by previous studies do not reflect survival outcomes observed in Black patients. Exome sequencing of Black AML pa…
Advancing the therapeutic landscape for Chronic Myelomonocytic Leukemia (CMML)
CMML is a universally lethal blood cancer characterized by increased monocytes (a type of white blood cell) in the peripheral blood and abnormal appea…
The Leukemia & Lymphoma Society® is now Blood Cancer United®
Today, The Leukemia & Lymphoma Society—now Blood Cancer United—unveiled its first national advertising campaign in more than a decade.
News Release
Histone methyltransferases as key dependencies in SETBP1-mutant leukemias
This study aims to explore how mutant SETBP1 affects histone methyltransferase complexes to drive gene transcription. I will use biochemical, imaging…
The Leukemia & Lymphoma Society's Response to the Israel-Hamas War
The following message was sent to all LLS employees on October , : Dear LLS Community, As an organization, The Leukemia & Lymphoma Society (LLS) is …
News Release
The Leukemia & Lymphoma Society Announces Reimagined Executive Leadership Team
See full multimedia release here.
News Release
Acute Lymphoblastic Leukemia: Diagnosis, Treatment and Side Effect Management
Click Here to ParticipateRecorded on: February , 2025Estimated Time to Complete: . hours2. CE Credits/Contact hours for nurses and social workers avai…
Education Resources
Targeted combination therapies for leukemia with NUP98 translocations
Leukemia patients with chromosomal translocations of the Nucleoporin (NUP98) gene suffer from very poor prognosis. In this project we will identify ne…
Lower Dose Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia
regimens are the standard of care for many patients with acute myeloid leukemia (AML) and are highly active therapeutic strategies for this challengin…